Literature DB >> 31853592

Fatal sulfasalazine-induced DRESS complicated by HHV-6 reactivation and hemophagocytic lymphohistiocytosis.

Helmi Ammar1, Abdelbaki Azouzi2, Neila Fathallah3, Mohamed Ahmed Boujelben2, Bouraoui Ouni3, Mohamed Boussarsar2, Badreddine Sriha4, Chaker Ben Salem3.   

Abstract

Entities:  

Year:  2019        PMID： 31853592     DOI： 10.1007/s00228-019-02809-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   3.064


× No keyword cloud information.
  7 in total

1.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

2.  Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis.

Authors:  Matthieu Picard; M Isabel Fernandez; Anne Des Roches; Philippe Bégin; Jean Paradis; Louis Paradis; Françoise Le Deist
Journal:  J Allergy Clin Immunol Pract       Date:  2013-05-27

Review 3.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  G E Janka
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

4.  Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.

Authors:  Neila Fathallah; Raoudha Slim; Salaheddine Rached; Wissem Hachfi; Amel Letaief; Chaker Ben Salem
Journal:  Int J Clin Pharm       Date:  2015-04-09

5.  Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.

Authors:  S H Kardaun; P Sekula; L Valeyrie-Allanore; Y Liss; C Y Chu; D Creamer; A Sidoroff; L Naldi; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

6.  Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus.

Authors:  Atsushi Komatsuda; Yohsuke Okamoto; Takashi Hatakeyama; Hideki Wakui; Ken-ichi Sawada
Journal:  Clin Rheumatol       Date:  2007-10-19       Impact factor: 2.980

7.  Drug Reaction with Eosinophilia and Systemic Symptoms Associated with Reactivation of Epstein-Barr Virus and/or Cytomegalovirus Leading to Hemophagocytic Syndrome in One of Two Patients.

Authors:  Jianhua Liang; Hui Qu; Xiaowen Wang; Aiping Wang; Lingling Liu; Ping Tu; Ruoyu Li; Mingyue Wang
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.